close Cancer vaccine cuts melanoma risk nearly 50% in breakthrough study A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period. The personalized mRNA cancer therapy, combined with the cancer immunotherapy drug KEYTRUDA, is a collaboration between Merck and Moderna. NEW You can now listen to Fox News articles! A vaccine created using artificial intelligence that could potentially provide broader protection against multiple coronaviruses and help

Tag-uri: Coronavirus